Cardio Diagnostics Holdings, Inc. Cash
Cardio Diagnostics Holdings, Inc. (CDIO) had Cash of $5.59 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash and Cash Equivalent
us-gaap:Cash · last filed 2026-08-07
- 2026-06-30: Cash $5.59M.
- 2026-03-31: Cash $7.08M.
- 2025-12-31: Cash $5.11M.
- 2025-09-30: Cash $6.36M.
| Period end | Cash | Cash as first filed |
|---|---|---|
| 2026-06-30 | $5.59M 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $7.08M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $5.11M 10-Q · filed 2026-08-07 | |
| 2025-09-30 | $6.36M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $7.97M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $9.69M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $7.83M 10-K · filed 2026-03-13 | |
| 2024-09-30 | $1.98M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $1.31M 10-Q · filed 2024-08-12 | |
| 2024-03-31 | $1.56M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $1.28M 10-K · filed 2025-03-20 | |
| 2023-09-30 | $3.63M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $5.04M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $6.71M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $4.12M 10-K · filed 2024-04-01 | |
| 2022-09-30 | $177.68K 10-Q · filed 2022-11-07 | |
| 2022-06-30 | $45.59K 10-Q · filed 2022-08-10 | |
| 2022-03-31 | $380.62K 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $512.77K 10-K · filed 2023-03-31 | $526.63K 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |